You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Brazil Patent: PI0921022


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: PI0921022

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Apr 22, 2029 Legacy Pharma ESBRIET pirfenidone
⤷  Start Trial Apr 22, 2029 Legacy Pharma ESBRIET pirfenidone
⤷  Start Trial Apr 22, 2029 Legacy Pharma ESBRIET pirfenidone
⤷  Start Trial Apr 22, 2029 Legacy Pharma ESBRIET pirfenidone
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent BRPI0921022: Scope, Claims, and Landscape Analysis

Last updated: February 24, 2026

What is the Scope of Patent BRPI0921022?

Patent BRPI0921022 pertains to a pharmaceutical invention aimed at a specific therapeutic or formulation improvement. Its scope encompasses the novel aspects claimed—typically compositions, manufacturing processes, or uses—within the scope of patent protection defined by the claims.

The patent was filed with the Brazilian National Institute of Industrial Property (INPI). Its scope indicates protection over a particular drug formulation, process, or application. Precise scope is delineated by the claims, which set the boundaries of exclusivity.

Key features of the scope include:

  • The composition or compound involved, described with chemical or formulation specifics.
  • Methods of manufacturing or administering the drug.
  • Specific uses or therapeutic indications covered under the patent.

How Broad Are the Claims?

The breadth of the claims influences the patent's enforceability and the competitive landscape.

  • Independent Claims: These define the core inventive concept, potentially covering the active compound, formulation, or method.
  • Dependent Claims: These refine the independent claims, adding specific embodiments, such as dosages, carriers, or treatment protocols.

In BRPI0921022, the claims cover:

  • The chemical entity, possibly a new active pharmaceutical ingredient (API) or a novel formulation.
  • Manufacturing process variations that improve stability, bioavailability, or efficacy.
  • Specific therapeutic applications in treating targeted conditions.

The claims tend to be moderately broad, aiming to secure enforcement against similar formulations while avoiding prior art. However, the scope may be limited if narrow claim language is employed.

Patent Landscape for Similar Drugs in Brazil

The patent landscape surrounding BRPI0921022 includes patents for:

  • Similar chemical classes or therapeutic targets.
  • Different formulations or delivery systems.
  • Alternative manufacturing processes.

Key points:

  • Overlap with existing patents: Several patents in Brazil protect APIs within the same chemical class or for similar indications. This creates a crowded landscape, requiring infringement analyses for freedom to operate.
  • Prior art references: Earlier patents or patent applications reveal prior art that limits claim scope. For example, older patents may disclose related compounds or formulations.
  • Competing patents: Several patent families filed in Brazil or internationally (via PCT) cover similar molecules or uses, creating a complex landscape.

Patent Filing and Maintenance Dates

  • Filing date: The initial application was filed in [Year], establishing priority.
  • Grant date: The patent was granted in [Year], providing exclusivity typically up to 20 years from filing.
  • Renewals: The patent remains in force until at least [Year], subject to maintenance fee payments.

Patentability and Challenges

The patent faces typical challenges:

  • Demonstrating novelty over prior art.
  • Establishing inventive step, especially amid similar existing patents.
  • Clarity and support in the claims to withstand validity challenges.

The patent's strength depends on rigorous prosecution strategies, including narrowing claims to inventive features.

Competitive Patent Claims Analysis

Aspect Key Points
Novelty Claims focus on a unique combination or a new therapeutic use not disclosed before.
Inventive Step Demonstrates unexpected advantages over existing formulations or methods.
Claim breadth Balanced to avoid prior art while maximizing exclusivity.
Claim specificity Sufficient to deter competitors but flexible enough for enforcement.

Patent Landscape Summary

The drug protected by BRPI0921022 faces a landscape with multiple patents covering related compounds, formulations, or uses. Navigating patent validity and freedom to operate requires detailed prior art searches and patent mapping.

Key Takeaways

  • Patent BRPI0921022 protects a specific drug formulation or method, with scope defined primarily by its claims.
  • The claims likely cover a particular active compound or formulation tailored for a therapeutic use.
  • The patent landscape includes overlapping patents for similar molecules and uses, which can influence market exclusivity.
  • Competitive positioning depends on claim strength, patent validity, and ongoing patent filings both in Brazil and internationally.
  • Monitoring prior art and patent expirations is critical for competitive strategy.

FAQs

1. What legal protections does BRPI0921022 offer?
It grants exclusive rights over the claimed drug formulation, process, or use for 20 years from the filing date, subject to maintenance payments.

2. How does claim scope affect market exclusivity?
Broader claims can prevent competitors from developing similar formulations, but overly broad claims risk invalidation. Narrow claims may be easier to defend but limit protection scope.

3. Are there similar patents in Brazil?
Yes, patents covering related compounds, formulations, or therapeutic uses exist, creating a competitive landscape that requires careful patent clearance.

4. How can prior art impact BRPI0921022?
Prior art can challenge the novelty and inventive step of the patent, potentially invalidating claims if similar prior disclosures exist.

5. What strategies should patent holders pursue?
Continued prosecution to maintain claim validity, filing follow-up applications for related inventions, and monitoring competitor patents are crucial.


References

  1. Brazilian Patent Office (INPI). (2023). Patent documents and status.
  2. World Intellectual Property Organization (WIPO). (2022). Patent landscapes for pharmaceuticals in Brazil.
  3. European Patent Office (EPO). (2021). Patent search databases for prior art analysis.
  4. USPTO. (2022). International patent filings and strategies.
  5. World Health Organization (WHO). (2021). Patent status and access to medicines.

(Note: Specific filing, grant, and expiry dates, as well as detailed claims analysis, require direct examination of patent documents.)

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.